Literature DB >> 24939382

Thrombus aspiration in primary angioplasty for ST-segment elevation myocardial infarction.

Roberta Serdoz1, Michele Pighi, Nikolaos V Konstantinidis, Ismail Dogu Kilic, Sara Abou-Sherif, Carlo Di Mario.   

Abstract

Mechanical reperfusion with primary percutaneous coronary intervention in acute ST-segment-elevation myocardial infarction is superior to fibrinolysis in terms of short-term and long-term outcome, provided that it can be delivered on time and by an experienced team. Balloon angioplasty and stent implantation of an occluded epicardial vessel during ST-segment-elevation myocardial infarction can cause disruption of the frail thrombus containing lesions associated with suboptimal myocardial reperfusion and microcirculatory obstruction. Distal embolization of atherothrombotic material can be prevented by thrombus aspiration during primary angioplasty. Mechanical aspiration via end-hole large-lumen thrombectomy catheters has been shown to improve Thrombolysis in Myocardial Infarction (TIMI) flow and result in a more consistent early resolution of ST-segment elevation in multiple registries. More recently, a more sophisticated quantification of the myocardial damage has been applied using myocardial scintigraphy and magnetic resonance, with no difference between patients treated with thrombectomy and patients treated with conventional therapy. The expectations in terms of lasting mortality benefit raised by the first Dutch single-center randomized trial of thrombectomy versus predilation with plain old balloon angioplasty (Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Myocardial Infarction, TAPAS) were not confirmed by a much larger Swedish trial (Thrombus Aspiration ST-Segment Elevation Myocardial Infarction, TASTE) showing no outcome changes. Although we are waiting for new trials to clarify these controversial results, thrombectomy is still used in selected patients with high thrombus load or with persistent occlusion of the infarct-related artery after wire passage. Here we review the various systems available and discuss their relative merits and the reported results.

Entities:  

Mesh:

Year:  2014        PMID: 24939382     DOI: 10.1007/s11883-014-0431-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  73 in total

1.  Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries.

Authors:  Gregg W Stone; David A Cox; Joseph Babb; Dean Nukta; Luc Bilodeau; Louis Cannon; Thomas D Stuckey; James Hermiller; Eric A Cohen; Reginald Low; Steven R Bailey; Alexandra J Lansky; Richard E Kuntz
Journal:  J Am Coll Cardiol       Date:  2003-12-03       Impact factor: 24.094

2.  Comparison of the in vitro performance of 6 and 7 French aspiration catheters.

Authors:  Hisao Hara; Masato Nakamura; Hirotaka Komatsu; Nobutaka Ikeda; Hideo Shinji; Kunihiko Makino; Hideki Itaya; Masaya Yamamoto; Naoki Itou; Taro Tsunoda; Kaoru Sugi
Journal:  EuroIntervention       Date:  2007-02       Impact factor: 6.534

3.  Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.

Authors:  K Mizuno; K Satomura; A Miyamoto; K Arakawa; T Shibuya; T Arai; A Kurita; H Nakamura; J A Ambrose
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  OCT-based diagnosis and management of STEMI associated with intact fibrous cap.

Authors:  Francesco Prati; Shiro Uemura; Geraud Souteyrand; Renu Virmani; Pascal Motreff; Luca Di Vito; Giuseppe Biondi-Zoccai; Jonathan Halperin; Valentin Fuster; Yukio Ozaki; Jagat Narula
Journal:  JACC Cardiovasc Imaging       Date:  2013-03

5.  MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial infarction pAtieNts-(GUARDIAN) trial: study design and rationale.

Authors:  Salvatore Cassese; Giovanni Esposito; Ciro Mauro; Ferdinando Varbella; Antonio Carraturo; Antonio Montinaro; Plinio Cirillo; Gennaro Galasso; Antonio Rapacciuolo; Federico Piscione
Journal:  Catheter Cardiovasc Interv       Date:  2012-03-14       Impact factor: 2.692

6.  Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis.

Authors:  S Constantinides; T S N Lo; M Been; M F Shiu
Journal:  Heart       Date:  2002-05       Impact factor: 5.994

7.  Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale.

Authors:  Ole Fröbert; Bo Lagerqvist; Thórarinn Gudnason; Leif Thuesen; Roger Svensson; Göran K Olivecrona; Stefan K James
Journal:  Am Heart J       Date:  2010-12       Impact factor: 4.749

8.  Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy.

Authors:  Takashi Kubo; Toshio Imanishi; Shigeho Takarada; Akio Kuroi; Satoshi Ueno; Takashi Yamano; Takashi Tanimoto; Yoshiki Matsuo; Takashi Masho; Hironori Kitabata; Kazushi Tsuda; Yoshiaki Tomobuchi; Takashi Akasaka
Journal:  J Am Coll Cardiol       Date:  2007-08-20       Impact factor: 24.094

9.  ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).

Authors:  Fernando A Cura; Marco Roffi; Narcis Pasca; Katherine E Wolski; A Michael Lincoff; Eric J Topol; Michael S Lauer
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

10.  Role of adenosine in hyperemic response of coronary blood flow in microembolization.

Authors:  M Hori; M Inoue; M Kitakaze; Y Koretsune; K Iwai; J Tamai; H Ito; A Kitabatake; T Sato; T Kamada
Journal:  Am J Physiol       Date:  1986-03
View more
  5 in total

Review 1.  [Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations].

Authors:  T Stiermaier; S de Waha; G Fürnau; I Eitel; H Thiele; S Desch
Journal:  Herz       Date:  2016-03-15       Impact factor: 1.443

2.  Evidence for a novel racemization process of an asparaginyl residue in mouse lysozyme under physiological conditions.

Authors:  K Ueno; T Ueda; K Sakai; Y Abe; N Hamasaki; M Okamoto; T Imoto
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

3.  MRI monitoring of function, perfusion and viability in microembolized moderately ischemic myocardium.

Authors:  Loi Do; Mark W Wilson; Roland Krug; Steven W Hetts; Maythem Saeed
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-08       Impact factor: 2.357

4.  A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.

Authors:  Min Ma; Ling Wang; Kai-Yue Diao; Shi-Chu Liang; Ye Zhu; Hua Wang; Mian Wang; Li Zhang; Zhi-Gang Yang; Yong He
Journal:  BMC Cardiovasc Disord       Date:  2022-02-04       Impact factor: 2.298

5.  Thrombus aspiration during primary percutaneous coronary intervention associated with reduced platelet activation.

Authors:  Muslum Sahin; Goksel Acar; Mehmet E Kalkan; Rezzan D Acar; Alev Kilicgedik; Burak Teymen; Ugur Arslantas; Cevat Kirma
Journal:  Saudi Med J       Date:  2015-08       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.